Belgian based company Alvalux Medical has appointed bébélephant as the UK distributor of their innovative CicaLux® energised scar-care treatment – which promises to improve both old and new scars without invasive procedures.

CicaLux is revolutionising the treatment of scars with a unique device which finds itself at the crossroads of aesthetic care and wearable tech. The CicaLux device has been designed to reduce the appearance of scars that appear following a C-Section or other surgery such as a tummy tuck or breast surgery. This extremely innovative solution has already received wide global acclaim, from winning a Bronze by UK Mother & Baby Awards for Best Innovative Maternity Skincare Award 2020, to winning Gold at the Mom’s Choice Awards in the USA and Top Innovation at the Victoires de la Beauté in France in 2019-20.

Announcing the UK launch, Founder and CEO of Alvalux, Michel Alvarez commented, “We see the UK as an important market for both award-winning CicaLux and  other complementary products we have in our pipeline. We are delighted to have appointed bébélephant to lead the UK advance, with their wide experience in launching innovative products in this market.”

Commenting on their appointment, Elliot Bishop, Managing Director of bébélephant noted, “CicaLux is a ground breaking product in the maternity space which will radically improve the lives of countless new mums. We are humbled to have been appointed to represent the company in the UK for such a product.”